National Guideline Clearinghouse | Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.
National Institute for Health and Care Excellence (NICE)
December 2, 2013
Guideline Title
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer.
Bibliographic Source(s)
| National Institute for Health and Care Excellence (NICE). Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer. London (UK): National Institute for Health and Care Excellence (NICE); 2013 May. 43 p. (Technology appraisal guidance; no. 285). |
Guideline Status
This is the current release of the guideline.
.png)
No hay comentarios:
Publicar un comentario